In continuation for development of 124I-labeled imaging pharmaceuticals, JS001 (Toripalimab, a humanized IgG mAb) was investigated for targeting human PD-L1 (hPD-L1) in a tumor mouse model [190]. Here, CD274 is linked to neoplasm.